- Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in GermanyThomas Witthöft
Medical Clinic I, Division of Gastroenterology, University of Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
Int J Colorectal Dis 20:18-23. 2005..The aim was to evaluate the efficacy and safety of repeated treatment with infliximab in patients with chronic active Crohn's disease under routine conditions in clinics and private practices...
- Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot studyTh Witthoeft
University Hospital Schleswig Holstein Campus Luebeck, Department of Medicine I, Division of Gastroenterology, Luebeck 23538, Germany
World J Gastroenterol 13:579-84. 2007..To investigate the use of high dose consensus-interferon in combination with ribavirin in former iv drug users infected with hepatitis C...
- Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety TrialTh Witthöft
Medical Department I, Division of Gastroenterology, University Hospital Schleswig Holstein Campus Lübeck, Lubeck, Germany
J Viral Hepat 14:788-96. 2007..This investigation confirms the well-known risk-benefit ratio found in controlled studies in a clinical practice setting. The safety profile is similar and shows the highest incidence of adverse events in the first 12 weeks of treatment...